Orthotopic GBM xenograft models

TL Tonny Lagerweij
SD Sophie A. Dusoswa
AN Adrian Negrean
EH Esther M. L. Hendrikx
HV Helga E. de Vries
JK Jeroen Kole
JG Juan J. Garcia-Vallejo
HM Huibert D. Mansvelder
WV W. Peter Vandertop
DN David P. Noske
BT Bakhos A. Tannous
RM René J. P. Musters
YK Yvette van Kooyk
PW Pieter Wesseling
XZ Xi Wen Zhao
TW Thomas Wurdinger
ask Ask a question
Favorite

Human GBM8 glioblastoma cells [27] and human E98 glioblastoma cells were lentivirally transduced with a lentivirus vector to stably express the mCherry fluorescent protein and firefly luciferase (Fluc) [28]. GBM8-FM cells were cultured as neurospheres in serum-free medium, supplemented with growth factors (2% of B27 supplement, 1% of N2 supplement, 2 µg/ml heparin, 20 ng/ml recombinant human EGF, 10 ng/ml recombinant human bFGF). E98-FM cells were injected subcutaneously in a donor mouse. When the tumor reached a diameter of 1 cm, the tumor was removed and a single-cell suspension was prepared. The harvested GBM cells were washed once with PBS and concentrated by centrifugation to a concentration of 1 × 105 cells per µl. Mice were stereotactically injected with 5 × 105 tumor cells into the striatum. Intracranial injections were performed under isoflurane anesthesia and systemic and topical analgesia (buprenorphine, 0.1 mg/kg; lidocaine 0.5%). The coordinates used for injections were 0.5 mm X, 2 mm Y, and −3 mm Z from the bregma [29]. Tumor progression was confirmed by Fluc in vivo bioluminescence imaging (BLI) after i.p. injection of d-luciferin (100 mg/kg) and acquiring the photon flux (p/s) using the Xenogen-IVIS Lumina system under isoflurane anesthesia.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A